Rheumatoid Arthritis Clinical Trials in Houston

Showing 1501-1520 of 1,660 trials

Hernia Repair in Multiply Morbid Patients

NCT00930787

Support of a ventral hernia repair with a prosthetic mesh has been demonstrated to result in a diminished rate of hernia recurrence. The patient with co-morbidities undergoing hernia repair is at increased risk of wound related complications, which may be exacerbated by the choice of prosthetic mesh, and which are known to influence the ultimate rate of hernia recurrence. It is hypothesized that patients receiving a mesh of biologic origin may experience fewer wound related complications and hence at least an equal rate of hernia recurrence, compared to those receiving a synthetic mesh.

Ventral Hernia

LifeCell23 participantsStarted Aug 2009

New Orleans, Louisiana, United States • New Orleans, Louisiana, United States • Baltimore, Maryland, United States +10 more locations

COMPLETEDNA< 1 mile

Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors

NCT00066482

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effect on the body of combining cyclophosphamide with cisplatin, etoposide, and bleomycin in treating children who have newly diagnosed malignant germ cell tumors that are not in the brain and gonads.

Childhood Germ Cell TumorExtragonadal Germ Cell Tumor

Children's Oncology Group19 participantsStarted Jul 2004

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +95 more locations

Hernia Repair in Multiply Morbid Patients

Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors

Rheumatoid Arthritis Trials in Other Cities

EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer

RESTART C0168Z05 Rheumatoid Arthritis Study

OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.

Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme

Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

Lobradimil and Carboplatin in Treating Children With Brain Tumors

An Open Label Extension Study in Subjects With Fragile X Syndrome

A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia

Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors

Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)

Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis

First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients

Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study

Other Conditions in Houston